Oxford Gene Technology

Founded by Professor Ed Southern, Oxford Gene Technology (OGT) is focused on providing innovative clinical genetics and diagnostic solutions to advance molecular medicine.

OGT’s innovative portfolio includes:

CytoSure™ — Providing clinical researchers with the complete array solution for the detection of chromosomal abnormalities, including class-leading products and fully accredited services, underpinned by exceptional interpretation software.

Genefficiency™ — Delivering comprehensive, high-quality microarray and targeted sequencing services to clinical and academic researchers.

Diagnostic Biomarkers — Providing tailored biomarker discovery solutions that optimise drug and diagnostic development programmes for pharmaceutical and molecular diagnostic companies.

Showing 1 of 1 results